Photo: Catheter tubing. Ed Cijs / Unsplash
FDA early alert: Arrow guidewire and PICC products pulled over coating that may shed emboli
A hydrophilic coating that swells unevenly and can flake off has Teleflex’s Arrow unit pulling guidewires and PICC kits.
The FDA on November 10 posted an early alert on Arrow International’s removal of products with spring wire guide components, including hydrophilic-coated guidewires, the VPS Precision Stylet, and Arrowg+ard Blue Advance and PICC/JACC catheters and kits [1]. Teleflex confirmed the coating may swell inconsistently in saline, clump and detach, releasing particles that could cause emboli, thrombosis, ischemia, stroke or death [1]. As of November 5 no serious injuries or deaths had been reported; affected devices should be quarantined and returned [1].
PAHO panel weighs whether the U.S. has lost measles elimination status
A verdict is expected early next week, and the signs are not encouraging.
A Pan American Health Organization expert panel began closed-door deliberations in Washington this week on whether U.S. measles transmission has continued uninterrupted for 12 months or longer [2], [3]. Noel Brewer, chair of an independent U.S. measles advisory panel, said the Arizona–Utah outbreak that began in June 2025 and is still going likely meets that criterion; Reuters counts nearly 7,500 U.S. cases and 11 deaths since early 2025 [2]. CDC Director Erica Schwartz said the agency would keep doing “the same exact thing” either way [2].
FDA approves Pimjetmi, a once-daily pill for tenosynovial giant cell tumor
EMD Serono’s kinase inhibitor is for adults whose tumors cannot be safely cut out.
On November 10 the FDA approved pimicotinib (Pimjetmi, EMD Serono) for adults with symptomatic TGCT for which surgical resection may cause worsening functional limitation or severe morbidity [4]. In the placebo-controlled MANEUVER trial, the week-25 overall response rate was 56% with pimicotinib versus 3.2% with placebo, with gains in range of motion, pain and physical function; common adverse reactions included pruritus, rash and facial edema, and the label warns of hepatotoxicity [4].
Queens adult day care director pleads guilty in $127 million Medicare and Medicaid fraud
Cash kickbacks to enrollees, bills for days patients were in the hospital, and a related pharmacy on the side.
Daniel Lee, 57, of Flushing, New York, program director at the Happy Life and Royal Adult Day Care centers, pleaded guilty on November 9 to conspiracy to commit health care fraud and conspiracy to commit money laundering [5]. Over roughly ten years, prosecutors say, the centers paid cash kickbacks to Medicaid recipients and billed for services never provided, some on days recipients were hospitalized, while Lee and co-conspirators paid kickbacks at a related pharmacy that billed for unnecessary prescriptions, costing Medicare and New York Medicaid about $127 million [5]. Sentencing is set for March 2, 2027; he faces up to 30 years [5].
Digest references
U.S. Food and Drug Administration. “Early Alert: Arrow International Removes Products Containing Spring Wire Guide Components.” FDA, November 10, 2026. https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-arrow-international-removes-products-containing-spring-wire-guide-components
Jennifer Rigby and Julie Steenhuysen. “US faces loss of measles-free status as experts meet for review.” Reuters (via SRN News), November 11, 2026. https://srnnews.com/us-faces-loss-of-measles-free-status-as-experts-meet-for-review/
Theresa Gaffney. “Morning Rounds: U.S. may soon lose measles elimination status.” STAT, November 11, 2026. https://www.statnews.com/2026/11/11/health-news-us-may-soon-lose-measles-elimination-status/
U.S. Food and Drug Administration. “FDA approves pimicotinib for symptomatic tenosynovial giant cell tumor.” FDA, November 10, 2026. https://www.fda.gov/drugs/cancer-approvals/fda-approves-pimicotinib-symptomatic-tenosynovial-giant-cell-tumor
U.S. Department of Justice, Office of Public Affairs. “Social Adult Day Care Program Director Pleads Guilty to $127M Medicare and Medicaid Fraud Scheme.” DOJ, November 10, 2026. https://www.justice.gov/opa/pr/social-adult-day-care-program-director-pleads-guilty-127m-medicare-and-medicaid-fraud-scheme